The market keeps winning. Most Americans are losing faith

U.S. stocks extended their winning streak to eight weeks, with the S&P 500 up 0.4% to 7,473.47, the Dow adding 294.04 points to 50,579.70, and the Nasdaq rising 0.2% to 26,343.97. The move came despite record-low U.S. consumer sentiment and rising inflation expectations, while Brent crude settled up 0.7% at $100.21 and the 10-year Treasury yield held near 4.56%. Strong earnings from Ross Stores (+8.1%), Estee Lauder (+11.9%), Workday (+5.2%), and Zoom (+9.2%) helped offset macro worries, and traders have now priced out Fed rate cuts later this year.

Analysis

The market is increasingly pricing a “good earnings, bad macro” regime: index-level resilience is being powered by company-specific execution while the consumer and rate backdrop deteriorate. That usually extends the tape for a while, but it also narrows leadership and raises dispersion—favoring names with real pricing power and balance-sheet flexibility over cyclical beta. The key second-order effect is that higher inflation expectations can keep rates elevated even if growth softens, which is the worst mix for long-duration equities and for companies dependent on cheap financing.

ROST is the clearest read-through on the consumer: off-price can still take share when households trade down, especially if tax-refund season temporarily boosts basket size. The risk is that this is a late-cycle “value migration” beneficiary, not a clean demand growth story; if inflation remains sticky and refund tailwinds fade, traffic can hold while ticket and margin quality compress. That makes the current reaction more defensible as a relative-value winner than as a sustained multiple re-rate.

WDAY and ZM are better viewed through the lens of cost discipline and enterprise budget prioritization. In a higher-rate world, software with tangible ROI and collaboration tools with embedded cost savings can keep beating on earnings even if top-line growth is mediocre, but the market will likely cap upside until there is clearer evidence of re-acceleration. The contrarian takeaway is that the strongest stocks may be those with the least exposure to capital-intensive growth—exactly where financing-sensitive competitors and AI infrastructure names become more vulnerable if yields stay around current levels.

Key Decisions for Investors

• Long ROST vs. XRT on a 4-8 week horizon: own the trade-down beneficiary while keeping retail beta hedged; target 1.5-2.0x upside if the market continues to reward defensive consumer share gainers, but cut if weekly consumer data rolls over and the move becomes purely relief-driven.
• Add WDAY on weakness, but only as a 1-2 month tactical long: earnings durability plus operating leverage should support the stock as long as rates stay contained; risk/reward is favorable into any pullback because the name is less rate-sensitive than broader software.
• Trade ZM as a relative short against a higher-quality software basket if the stock gaps again: upside is likely capped by slower secular growth, while any yield backup quickly compresses long-duration multiples; use tight risk controls because earnings beats can extend momentum for several sessions.
• Short a basket of rate-sensitive, capital-intensive growth names versus a basket of profitable software/defensive retail: the macro setup favors companies that can self-fund growth if 10-year yields remain in the mid-4% range or higher.
• For event-driven positioning, buy short-dated downside hedges on the S&P 500 or Nasdaq into further oil volatility: the equity index can grind higher on earnings, but the combination of sticky inflation expectations and no Fed cuts creates a fragile ceiling beyond the next 1-2 months.